Trabajos de Josep Tabernero

Clinical Medicine


  Listando 186 trabajos del autor/autora 39
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   4   News   0   Policy
Article Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer Pinato, David J.; Zambelli, Alberto; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Mesia, Ricard; Segui, Elia; Biello, Federica; Generali, Daniele; Grisanti, Salvatore; Rizzo, Gianpiero; Liberti CANCER DISCOVERY 2159-8274 (2020) DOI / 10.1158/2159-8290.cd-20-0773 Green published, Bronze
Mentions   2   Wikipedia   33   News   0   Policy
Article Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer Bullman, Susan; Pedamallu, Chandra S.; Sicinska, Ewa; Claney, Thomas E.; Zhang, Xiaoyang; Cai, Diana; Neuberg, Donna; Huang, Katherine; Guevara, Fatima; Nelson, Timothy; Chipashvili, Otari; Hagan, Timothy; Walker, Mark; Ramachandran, Aruna; Diosdado, Begon SCIENCE 0036-8075 (2017) DOI / 10.1126/science.aal5240 Green accepted, Bronze
Mentions   1   Wikipedia   55   News   0   Policy
Review Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review Garcia-Foncillas, J.; Alba, E.; Aranda, E.; Diaz-Rubio, E.; Lopez-Lopez, R.; Tabernero, J.; Vivancos, A. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx501 Gold other, Green published
Mentions   2   Wikipedia   54   News   1   Policy
Article Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials Arnold, D.; Lueza, B.; Douillard, J. -Y.; Peeters, M.; Lenz, H. -J.; Venook, A.; Heinemann, V.; Van Cutsem, E.; Pignon, J. -P.; Tabernero, J.; Cervantes, A.; Ciardiello, F. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx175 Green published, Bronze
Mentions   1   Wikipedia   53   News   0   Policy
Article Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer Grasselli, J.; Elez, E.; Caratu, G.; Matito, J.; Santos, C.; Macarulla, T.; Vidal, J.; Garcia, M.; Vieitez, J. M.; Paez, D.; Falco, E.; Lopez Lopez, C.; Aranda, E.; Jones, F.; Sikri, V.; Nuciforo, P.; Fasani, R.; Tabernero, J.; Montagut, C.; Azuara, D.; Di ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx112 Green published, Hybrid
Mentions   0   Wikipedia   53   News   0   Policy
Review Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall? Hierro, C.; Alsina, M.; Sanchez, M.; Serra, V.; Rodon, J.; Tabernero, J. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx081 Bronze
Mentions   0   Wikipedia   41   News   1   Policy
Article Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer Kopetz, S.; Grothey, A.; Yaeger, R.; Van Cutsem, E.; Desai, J.; Yoshino, T.; Wasan, H.; Ciardiello, F.; Loupakis, F.; Hong, Y. S.; Steeghs, N.; Guren, T. K.; Arkenau, H. -T.; Garcia-Alfonso, P.; Pfeiffer, P.; Orlov, S.; Lonardi, S.; Elez, E.; Kim, T. -W.; NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2019) DOI / 10.1056/nejmoa1908075 Bronze, Green published
Mentions   0   Wikipedia   61   News   0   Policy
Article Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial Rodon, Jordi; Soria, Jean-Charles; Berger, Raanan; Miller, Wilson H.; Rubin, Eitan; Kugel, Aleksandra; Tsimberidou, Apostolia; Saintigny, Pierre; Ackerstein, Aliza; Brana, Irene; Loriot, Yohann; Afshar, Mohammad; Miller, Vincent; Wunder, Fanny; Bresson, Ca NATURE MEDICINE 1078-8956 (2019) DOI / 10.1038/s41591-019-0424-4 Green accepted
Mentions   0   Wikipedia   17   News   2   Policy
Article Caring for patients with cancer in the COVID-19 era van de Haar, Joris; Hoes, Louisa R.; Coles, Charlotte E.; Seamon, Kenneth; Frohling, Stefan; Jager, Dirk; Valenza, Franco; De Braud, Filippo; de Petris, Luigi; Bergh, Jonas; Ernberg, Ingemar; Besse, Benjamin; Barlesi, Fabrice; Garralda, Elena; Piris-Gimene NATURE MEDICINE 1078-8956 (2020) DOI / 10.1038/s41591-020-0874-8 Bronze
Mentions   0   Wikipedia   29   News   3   Policy
Article Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial Shitara, Kohei; Doi, Toshihiko; Dvorkin, Mikhail; Mansoor, Wasat; Arkenau, Hendrik-Tobias; Prokharau, Aliaksandr; Alsina, Maria; Ghidini, Michele; Faustino, Catia; Gorbunova, Vera; Zhavrid, Edvard; Nishikawa, Kazuhiro; Hosokawa, Ayumu; Yalcin, Suayib; Fuji LANCET ONCOLOGY 1470-2045 (2018) DOI / 10.1016/s1470-2045(18)30739-3
Mentions   0   Wikipedia   14   News   0   Policy
Article The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer Janjigian, Yelena Y.; Kawazoe, Akihito; Yanez, Patricio; Li, Ning; Lonardi, Sara; Kolesnik, Oleksii; Barajas, Olga; Bai, Yuxian; Shen, Lin; Tang, Yong; Wyrwicz, Lucjan S.; Xu, Jianming; Shitara, Kohei; Qin, Shukui; Van Cutsem, Eric; Tabernero, Josep; Li, L NATURE (2021) DOI / 10.1038/s41586-021-04161-3
Mentions   0   Wikipedia   27   News   0   Policy
Article TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence Puig, Isabel; Tenbaum, Stephan P.; Chicote, Irene; Arques, Oriol; Martinez-Quintanilla, Jordi; Cuesta-Borras, Estefania; Ramirez, Lorena; Gonzalo, Pilar; Soto, Atenea; Aguilar, Susana; Eguizabal, Cristina; Caratu, Ginevra; Prat, Aleix; Argiles, Guillem; La JOURNAL OF CLINICAL INVESTIGATION 0021-9738 (2018) DOI / 10.1172/jci96393 Bronze, Green published
Mentions   0   Wikipedia   12   News   0   Policy
Article Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment Rubio-Perez, Carlota; Planas-Rigol, Ester; Trincado, Juan L.; Bonfill-Teixidor, Ester; Arias, Alexandra; Marchese, Domenica; Moutinho, Catia; Serna, Garazi; Pedrosa, Leire; Iurlaro, Raffaella; Martinez-Ricarte, Francisco; Escudero, Laura; Cordero, Esteban; NATURE COMMUNICATIONS (2021) DOI / 10.1038/s41467-021-21789-x Green published, Gold
Mentions   3   Wikipedia   21   News   5   Policy
Article ESMO-Magnitude of Clinical Benefit Scale version 1.1 Cherny, N. I.; Dafni, U.; Bogaerts, J.; Latino, N. J.; Pentheroudakis, G.; Douillard, J. -Y.; Tabernero, J.; Zielinski, C.; Piccart, M. J.; De Vries, E. G. E. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx310 Bronze
Mentions   0   Wikipedia   26   News   0   Policy
Article Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy Subgroup Analyses of a Randomized Clinical Trial Ilson, David H.; Tabernero, Josep; Prokharau, Aliaksandr; Arkenau, Hendrik-Tobias; Ghidini, Michele; Fujitani, Kazumasa; Van Cutsem, Eric; Thuss-Patience, Peter; Beretta, Giordano D.; Mansoor, Wasat; Zhavrid, Edvard; Alsina, Maria; George, Ben; Catenacci, JAMA ONCOLOGY 2374-2437 (2020) DOI / 10.1001/jamaoncol.2019.3531 Green published, Gold other
Mentions   0   Wikipedia   5   News   0   Policy
Letter Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal Tamborero, David; Dienstmann, Rodrigo; Rachid, Maan Haj; Boekel, Jorrit; Baird, Richard; Brana, Irene; de Petris, Luigi; Yachnin, Jeffrey; Massard, Christophe; Opdam, Frans L.; Schlenk, Richard; Vernieri, Claudio; Garralda, Elena; Masucci, Michele; Villalo NATURE MEDICINE 1078-8956 (2020) DOI / 10.1038/s41591-020-0969-2
Mentions   0   Wikipedia   0   News   0   Policy
Review Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring Gyawali, B.; De Vries, E. G. E.; Dafni, U.; Amaral, T.; Barriuso, J.; Bogaerts, J.; Calles, A.; Curigliano, G.; Gomez-Roca, C.; Kiesewetter, B.; Oosting, S.; Passaro, A.; Pentheroudakis, G.; Piccart, M.; Roitberg, F.; Tabernero, J.; Tarazona, N.; Trapani, ESMO OPEN (2021) DOI / 10.1016/j.esmoop.2021.100117 Gold, Green published
Mentions   0   Wikipedia   12   News   0   Policy
Article p95HER2-T cell bispecific antibody for breast cancer treatment Rius Ruiz, Irene; Vicario, Rocio; Morancho, Beatriz; Bernado Morales, Cristina; Arenas, Enrique J.; Herter, Sylvia; Freimoser-Grundschober, Anne; Somandin, Jitka; Sam, Johannes; Ast, Oliver; Martinez Barriocanal, Agueda; Luque, Antonio; Escorihuela, Marta; SCIENCE TRANSLATIONAL MEDICINE 1946-6234 (2018) DOI / 10.1126/scitranslmed.aat1445 Bronze, Green accepted
Mentions   0   Wikipedia   5   News   0   Policy
Article Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial Shitara, Kohei; Van Cutsem, Eric; Bang, Yung-Jue; Fuchs, Charles; Wyrwicz, Lucjan; Lee, Keun-Wook; Kudaba, Iveta; Garrido, Marcelo; Chung, Hyun Cheol; Lee, Jeeyun; Castro, Hugo Raul; Mansoor, Wasat; Braghiroli, Maria Ignez; Karaseva, Nina; Caglevic, Christ JAMA ONCOLOGY 2374-2437 (2020) DOI / 10.1001/jamaoncol.2020.3370
Mentions   0   Wikipedia   8   News   1   Policy
Article Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy A Pooled Analysis From 2 Randomized Clinical Trials Zaanan, Aziz; Shi, Qian; Taieb, Julien; Alberts, Steven R.; Meyers, Jeffrey P.; Smyrk, Thomas C.; Julie, Catherine; Zawadi, Ayman; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Van Laethem, Jean Luc; Le Malicot, Karine; Sargent, JAMA ONCOLOGY 2374-2437 (2018) DOI / 10.1001/jamaoncol.2017.2899 Green published
Mentions   0   Wikipedia   5   News   0   Policy
Article Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer Retrospective Analyses of the CRYSTAL and FIRE-3 Trials Tejpar, Sabine; Stintzing, Sebastian; Ciardiello, Fortunato; Tabernero, Josep; Van Cutsem, Eric; Beier, Frank; Esser, Regina; Lenz, Heinz-Josef; Heinemann, Volker JAMA ONCOLOGY 2374-2437 (2017) DOI / 10.1001/jamaoncol.2016.3797 Green accepted
Mentions   0   Wikipedia   2   News   0   Policy
Article Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy Hodi, F. Stephen; Ballinger, Marcus; Lyons, Benjamin; Soria, Jean-Charles; Nishino, Mizuki; Tabernero, Josep; Powles, Thomas; Smith, David; Hoos, Axel; McKenna, Chris; Beyer, Ulrich; Rhee, Ina; Fine, Gregg; Winslow, Nathan; Chen, Daniel S.; Wolchok, Jedd D JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2018) DOI / 10.1200/jco.2017.75.1644
Mentions   0   Wikipedia   0   News   0   Policy
Article Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas Capdevila, Jaume; Arques, Oriol; Hernandez Mora, Jose Ramon; Matito, Judit; Caratu, Ginevra; Mancuso, Francesco M.; Landolfi, Stefania; Barriuso, Jorge; Jimenez-Fonseca, Paula; Lopez Lopez, Carlos; Garcia-Carbonero, Rocio; Hernando, Jorge; Matos, Ignacio; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-1266 Bronze
Mentions   0   Wikipedia   5   News   0   Policy
Article Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses A Phase 2 Randomized Clinical Trial Montagut, Clara; Argiles, Guillem; Ciardiello, Fortunato; Poulsen, Thomas T.; Dienstmann, Rodrigo; Kragh, Michael; Kopetz, Scott; Lindsted, Trine; Ding, Cliff; Vidal, Joana; Clausell-Tormos, Jenifer; Siravegna, Giulia; Sanchez-Martin, Francisco J.; Koefoed JAMA ONCOLOGY 2374-2437 (2018) DOI / 10.1001/jamaoncol.2017.5245 Green published, Bronze
Mentions   0   Wikipedia   2   News   0   Policy
Article Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey Banerjee, S.; Califano, R.; Corral, J.; De Azambuja, E.; De Mattos-Arruda, L.; Guarneri, V.; Hutka, M.; Jordan, K.; Martinelli, E.; Mountzios, G.; Ozturk, M. A.; Petrova, M.; Postel-Vinay, S.; Preusser, M.; Qvortrup, C.; Volkov, M. N. M.; Tabernero, J.; Ol ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx196 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material CANCER A precision approach to tumour treatment Dienstmann, Rodrigo; Tabernero, Josep NATURE 0028-0836 (2017) DOI / 10.1038/nature23101 Bronze
Mentions   0   Wikipedia   2   News   0   Policy
Article Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status Taieb, Julien; Kourie, Hampig Raphael; Emile, Jean-Francois; Le Malicot, Karine; Balogoun, Ralyath; Tabernero, Josep; Mini, Enrico; Folprecht, Gunnar; Van Laethem, Jean-Luc; Mulot, Claire; Bouche, Olivier; Aparicio, Thomas; Michel, Pierre; Thaler, Josef; B JAMA ONCOLOGY 2374-2437 (2018) DOI / 10.1001/jamaoncol.2017.3695 Green published, Bronze
Mentions   0   Wikipedia   3   News   0   Policy
Article Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT) Marabelle, A.; Andtbacka, R.; Harrington, K.; Melero, I.; Leidner, R.; de Baere, T.; Robert, C.; Ascierto, P. A.; Baurain, J-F; Imperiale, M.; Rahimian, S.; Tersago, D.; Klumper, E.; Hendriks, M.; Kumar, R.; Stern, M.; Ohrling, K.; Massacesi, C.; Tchakov, ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy423 Green published, Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article Global cancer control: responding to the growing burden, rising costs and inequalities in access Prager, Gerald W.; Braga, Sofia; Bystricky, Branislav; Qvortrup, Camilla; Criscitiello, Carmen; Esin, Ece; Sonke, Gabe S.; Martinez, Guillem Argiles; Frenel, Jean-Sebastian; Karamouzis, Michalis; Strijbos, Michiel; Yazici, Ozan; Bossi, Paolo; Banerjee, Sus ESMO OPEN (2018) DOI / 10.1136/esmoopen-2017-000285 Gold DOAJ, Green published
Mentions   0   Wikipedia   6   News   0   Policy
Article Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival Lazar, Vladimir; Magidi, Shai; Girard, Nicolas; Savignoni, Alexia; Martini, Jean-Francois; Massimini, Giorgio; Bresson, Catherine; Berger, Raanan; Onn, Amir; Raynaud, Jacques; Wunder, Fanny; Berindan-Neagoe, Ioana; Sekacheva, Marina; Brana, Irene; Taberner NPJ PRECISION ONCOLOGY (2021) DOI / 10.1038/s41698-021-00171-6 Gold DOAJ, Green published
Mentions   0   Wikipedia   4   News   0   Policy
Review Preparing for the incoming wave of biosimilars in oncology Wolff-Holz, Elena; Burgos, Juan Garcia; Giuliani, Rosa; Befrits, Gustaf; De Munter, Johan; Avedano, Luisa; Aitken, Murray; Gonzalez-Quevedo, Rosa; Vyas, Malvika; de Vries, Elisabeth G. E.; Tabernero, Josep ESMO OPEN (2018) DOI / 10.1136/esmoopen-2018-000420 Gold DOAJ, Green published
Mentions   0   Wikipedia   7   News   0   Policy
Article Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study Tabernero, Josep; Grothey, Axel; Van Cutsem, Eric; Yaeger, Rona; Wasan, Harpreet; Yoshino, Takayuki; Desai, Jayesh; Ciardiello, Fortunato; Loupakis, Fotios; Hong, Yong Sang; Steeghs, Neeltje; Guren, Tormod Kyrre; Arkenau, Hendrik-Tobias; Garcia-Alfonso, Pi JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2021) DOI / 10.1200/jco.20.02088 Green published, Gold other
Mentions   0   Wikipedia   5   News   0   Policy
Article Towards a cancer mission in Horizon Europe: recommendations Berns, Anton; Ringborg, Ulrik; Celis, Julio E.; Heitor, Manuel; Aaronson, Neil K.; Abou-Zeid, Nancy; Adami, Hans-Olov; Apostolidis, Kathi; Baumann, Michael; Bardelli, Alberto; Bernards, Rene; Brandberg, Yvonne; Caldas, Carlos; Calvo, Fabien; Dive, Caroline MOLECULAR ONCOLOGY 1574-7891 (2020) DOI / 10.1002/1878-0261.12763 Gold DOAJ, Green published
Mentions   0   Wikipedia   6   News   1   Policy
Article Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus Curigliano, G.; Banerjee, S.; Cervantes, A.; Garassino, M. C.; Garrido, P.; Girard, N.; Haanen, J.; Jordan, K.; Lordick, F.; Machiels, J. P.; Michielin, O.; Peters, S.; Tabernero, J.; Douillard, J. Y.; Pentheroudakis, G. ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.07.010 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Review Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer Dienstmann, Rodrigo; Vermeulen, Louis; Guinney, Justin; Kopetz, Scott; Tejpar, Sabine; Tabernero, Josep NATURE REVIEWS CANCER 1474-175X (2017) DOI / 10.1038/nrc.2016.126
Mentions   0   Wikipedia   5   News   0   Policy
Article Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score Cherny, Nathan I.; de Vries, Elisabeth G. E.; Dafni, Urania; Garrett-Mayer, Elizabeth; McKernin, Shannon E.; Piccart, Martine; Latino, Nicola J.; Douillard, Jean-Yves; Schnipper, Lowell E.; Somerfield, Mark R.; Bogaerts, Jan; Karlis, Dimitris; Zygoura, Pan JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2019) DOI / 10.1200/jco.18.00729
Mentions   0   Wikipedia   5   News   0   Policy
Review BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives Sanz-Garcia, E.; Argiles, G.; Elez, E.; Tabernero, J. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx401 Bronze
Mentions   0   Wikipedia   2   News   1   Policy
Article Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study Van Cutsem, Eric; Huijberts, Sanne; Grothey, Axel; Yaeger, Rona; Cuyle, Pieter-Jan; Elez, Elena; Fakih, Marwan; Montagut, Clara; Peeters, Marc; Yoshino, Takayuki; Wasan, Harpreet; Desai, C. Jayesh; Ciardiello, Fortunato; Gollerkeri, Ashwin; Christy-Bittel, JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2019) DOI / 10.1200/jco.18.02459 Green published, Gold other, Green accepted
Mentions   0   Wikipedia   2   News   0   Policy
Article A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors Ligero, Marta; Garcia-Ruiz, Alonso; Viaplana, Cristina; Villacampa, Guillermo; Raciti, Maria, V; Landa, Jaid; Matos, Ignacio; Martin-Liberal, Juan; Ochoa-de-Olza, Maria; Hierro, Cinta; Mateo, Joaquin; Gonzalez, Macarena; Morales-Barrera, Rafael; Suarez, Cr RADIOLOGY 0033-8419 (2021) DOI / 10.1148/radiol.2021200928
Mentions   0   Wikipedia   1   News   0   Policy
Article Combined BRAF, EGFR, and MEK Inhibition in Patients with &ITBRAF&ITV600E-Mutant Colorectal Cancer Corcoran, Ryan B.; Andre, Thierry; Atreya, Chloe E.; Schellens, Jan H. M.; Yoshino, Takayuki; Bendell, Johanna C.; Hollebecque, Antoine; McRee, Autumn J.; Siena, Salvatore; Middleton, Gary; Muro, Kei; Gordon, Michael S.; Tabernero, Josep; Yaeger, Rona; O'D CANCER DISCOVERY 2159-8274 (2018) DOI / 10.1158/2159-8290.cd-17-1226 Green published, Green accepted, Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials Chao, Joseph; Fuchs, Charles S.; Shitara, Kohei; Tabernero, Josep; Muro, Kei; Van Cutsem, Eric; Bang, Yung-Jue; De Vita, Ferdinando; Landers, Gregory; Yen, Chia-Jui; Chau, Ian; Elme, Anneli; Lee, Jeeyun; Ozguroglu, Mustafa; Catenacci, Daniel; Yoon, Harry H JAMA ONCOLOGY 2374-2437 (2021) DOI / 10.1001/jamaoncol.2021.0275
Mentions   0   Wikipedia   1   News   0   Policy
Review Enhancing anti-tumour efficacy with immunotherapy combinations Meric-Bernstam, Funda; Larkin, James; Tabernero, Josep; Bonini, Chiara LANCET 0140-6736 (2021) DOI / 10.1016/s0140-6736(20)32598-8
Mentions   0   Wikipedia   1   News   1   Policy
Article The Porto European Cancer Research Summit 2021 Ringborg, Ulrik; Berns, Anton; Celis, Julio E.; Heitor, Manuel; Tabernero, Josep; Schuz, Joachim; Baumann, Michael; Henrique, Rui; Aapro, Matti; Basu, Partha; Beets-Tan, Regina; Besse, Benjamin; Cardoso, Fatima; Carneiro, Fatima; Van den Eede, Guy; Eggermo MOLECULAR ONCOLOGY 1574-7891 (2021) DOI / 10.1002/1878-0261.13078 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria Matos, Ignacio; Martin-Liberal, Juan; Garcia-Ruiz, Alonso; Hierro, Cinta; Ochoa de Olza, Maria; Viaplana, Cristina; Azaro, Analia; Vieito, Maria; Brana, Irene; Mur, Gemma; Ros, Javier; Mateos, Jose; Villacampa, Guillermo; Berche, Roger; Oliveira, Mafalda; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-2226 Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS Yoshino, T.; Arnold, D.; Taniguchi, H.; Pentheroudakis, G.; Yamazaki, K.; Xu, R. -H.; Kim, T. W.; Ismail, F.; Tan, I. B.; Yeh, K. -H.; Grothey, A.; Zhang, S.; Ahn, J. B.; Mastura, M. Y.; Chong, D.; Chen, L. -T.; Kopetz, S.; Eguchi-Nakajima, T.; Ebi, H.; Oh ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdx738 Gold other
Mentions   0   Wikipedia   1   News   1   Policy
Article Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study Tabernero, Josep; Hoff, Paulo M.; Shen, Lin; Ohtsu, Atsushi; Shah, Manish A.; Cheng, Karen; Song, Chunyan; Wu, Haiyan; Eng-Wong, Jennifer; Kim, Katherine; Kong, Yoon-Koo LANCET ONCOLOGY 1470-2045 (2018) DOI / 10.1016/s1470-2045(18)30481-9
Mentions   2   Wikipedia   1   News   0   Policy
Article Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors Bahleda, Rastislav; Italiano, Antoine; Hierro, Cinta; Mita, Alain; Cervantes, Andres; Chan, Nancy; Awad, Mark; Calvo, Emiliano; Moreno, Victor; Govindan, Ramaswamy; Spira, Alexander; Gonzalez, Martha; Zhong, Bob; Santiago-Walker, Ademi; Poggesi, Italo; Par CLINICAL CANCER RESEARCH 1078-0432 (2019) DOI / 10.1158/1078-0432.ccr-18-3334 Bronze
Mentions   0   Wikipedia   3   News   0   Policy
Article Phosphatidylinositol 3-Kinase -Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study Juric, Dejan; Rodon, Jordi; Tabernero, Josep; Janku, Filip; Burris, Howard A.; Schellens, Jan H. M.; Middleton, Mark R.; Berlin, Jordan; Schuler, Martin; Gil-Martin, Marta; Rugo, Hope S.; Seggewiss-Bernhardt, Ruth; Huang, Alan; Bootle, Douglas; Demanse, Da JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2018) DOI / 10.1200/jco.2017.72.7107 Green published, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials Dienstmann, Rodrigo; Garralda, Elena; Aguilar, Susana; Sala, Gemma; Viaplana, Cristina; Ruiz-Pace, Fiorella; Gonzalez-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Ramos Masdeu, Laia; Mancuso, Francesco; Fasani, Roberta; Jimenez, Jose; Mart JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.19.00398 Gold other, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour -agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions Yoshino, T.; Pentheroudakis, G.; Mishima, S.; Overman, M. J.; Yeh, K. -H.; Baba, E.; Naito, Y.; Calvo, F.; Saxena, A.; Chen, L. -T.; Takeda, M.; Cervantes, A.; Taniguchi, H.; Yoshida, K.; Kodera, Y.; Kitagawa, Y.; Tabernero, J.; Burris, H.; Douillard, J. - ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.03.299 Bronze
Mentions   0   Wikipedia   0   News   2   Policy
Editorial Material Shortages of inexpensive essential medicines Vyas, Malvika; de Vries, Elisabeth G. E.; Casali, Paolo G.; Tabernero, Josep LANCET ONCOLOGY 1470-2045 (2019) DOI / 10.1016/s1470-2045(19)30248-7
Mentions   0   Wikipedia   0   News   0   Policy
Article Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer Serna, G.; Ruiz-Pace, F.; Hernando, J.; Alonso, L.; Fasani, R.; Landolfi, S.; Comas, R.; Jimenez, J.; Elez, E.; Bullman, S.; Tabernero, J.; Capdevila, J.; Dienstmann, R.; Nuciforo, P. ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.06.003 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review The expanding role of immunotherapy Martin-Liberal, Juan; Ochoa de Olza, Maria; Hierro, Cinta; Gros, Alena; Rodon, Jordi; Tabernero, Josep CANCER TREATMENT REVIEWS 0305-7372 (2017) DOI / 10.1016/j.ctrv.2017.01.008
Mentions   0   Wikipedia   3   News   0   Policy
Article Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey Garrido, P.; Adjei, A. A.; Bajpai, J.; Banerjee, S.; Berghoff, A. S.; Choo, S. P.; Felip, E.; Furness, A. J. S.; Garralda, E.; Haanen, J.; Letsch, A.; Linardou, H.; Peters, S.; Sessa, C.; Tabernero, J.; Tsang, J.; Yang, J. C-H; Garassino, M. C. ESMO OPEN (2021) DOI / 10.1016/j.esmoop.2021.100131 Gold, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Argiles, G.; Tabernero, J.; Labianca, R.; Hochhauser, D.; Salazar, R.; Iveson, T.; Laurent-Puig, P.; Quirke, P.; Yoshino, T.; Taieb, J.; Martinelli, E.; Arnold, D. ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.06.022 Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid Martinez-Ricarte, Francisco; Mayor, Regina; Martinez-Saez, Elena; Rubio-Perez, Carlota; Pineda, Estela; Cordero, Esteban; Cicuendez, Marta; Poca, Maria A.; Lopez-Bigas, Nuria; Ramon y Cajal, Santiago; Vieito, Maria; Carles, Joan; Tabernero, Josep; Vivancos CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-17-3800 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology Giuliani, Rosa; Tabernero, Josep; Cardoso, Fatima; McGregor, Keith Hanson; Vyas, Malvika; de Vries, Elisabeth G. E. ESMO OPEN (2019) DOI / 10.1136/esmoopen-2018-000460 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials Matos, Ignacio; Villacampa, Guillermo; Hierro, Cinta; Martin-Liberal, Juan; Berche, Roger; Pedrola, Anna; Brana, Irene; Azaro, Analia; Vieito, Maria; Saavedra, Omar; Gardeazabal, Itziar; Hernando-Calvo, Alberto; Alonso, Guzman; Galvao, Vladimir; de Olza, M EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.05.040 Hybrid
Mentions   0   Wikipedia   1   News   0   Policy
Article HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastr Shah, Manish A.; Xu, Rui-hua; Bang, Yung-Jue; Hoff, Paulo M.; Liu, Tianshu; Herraez-Baranda, Luis A.; Xia, Fan; Garg, Amit; Shing, Mona; Tabernero, Josep JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2017) DOI / 10.1200/jco.2016.71.6852
Mentions   0   Wikipedia   0   News   0   Policy
Review Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges Bradley, Conor A.; Salto-Tellez, Manuel; Laurent-Puig, Pierre; Bardelli, Alberto; Rolfo, Christian; Tabernero, Josep; Khawaja, Hajrah A.; Lawler, Mark; Johnston, Patrick G.; Van Schaeybroeck, Sandra NATURE REVIEWS CLINICAL ONCOLOGY 1759-4774 (2017) DOI / 10.1038/nrclinonc.2017.40
Mentions   0   Wikipedia   0   News   0   Policy
Review Precision oncology in metastatic colorectal cancer - from biology to medicine Di Nicolantonio, Federica; Vitiello, Pietro Paolo; Marsoni, Silvia; Siena, Salvatore; Tabernero, Josep; Trusolino, Livio; Bernards, Rene; Bardelli, Alberto NATURE REVIEWS CLINICAL ONCOLOGY 1759-4774 (2021) DOI / 10.1038/s41571-021-00495-z
Mentions   0   Wikipedia   1   News   0   Policy
Article A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations Voss, Martin H.; Hierro, Cinta; Heist, Rebecca S.; Cleary, James M.; Meric-Bernstam, Funda; Tabernero, Josep; Janku, Filip; Gandhi, Leena; Iafrate, A. John; Borger, Darrell R.; Ishii, Nobuya; Hu, Youyou; Kirpicheva, Yulia; Nicolas-Metral, Valerie; Pokorska CLINICAL CANCER RESEARCH 1078-0432 (2019) DOI / 10.1158/1078-0432.ccr-18-1959 Bronze
Mentions   0   Wikipedia   0   News   2   Policy
Article Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study Yoshino, T.; Portnoy, D. C.; Obermannova, R.; Bodoky, G.; Prausova, J.; Garcia-Carbonero, R.; Ciuleanu, T.; Garcia-Alfonso, P.; Cohn, A. L.; Van Cutsem, E.; Yamazaki, K.; Lonardi, S.; Muro, K.; Kim, T. W.; Yamaguchi, K.; Grothey, A.; O'Connor, J.; Taieb, J ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdy461 Green published, Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe Pinato, David J.; Lee, Alvin J. X.; Biello, Federica; Segui, Elia; Aguilar-Company, Juan; Carbo, Anna; Bruna, Riccardo; Bower, Mark; Rizzo, Gianpiero; Benafif, Sarah; Carmona, Carme; Chopra, Neha; Cruz, Claudia Andrea; D'Avanzo, Francesca; Evans, Joanne S. CANCERS (2020) DOI / 10.3390/cancers12071841 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer Cardone, Claudia; Blauensteiner, Bernadette; Moreno-Viedma, Veronica; Martini, Giulia; Simeon, Vittorio; Vitiello, Pietro P.; Ciardiello, Davide; Belli, Valentina; Matrone, Nunzia; Troiani, Teresa; Morgillo, Floriana; Marino, Federica Zito; Dentice, Monica EUROPEAN JOURNAL OF CANCER 0959-8049 (2020) DOI / 10.1016/j.ejca.2020.07.010
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material All change: closing the gender gap in oncology Tabernero, Josep ESMO OPEN (2018) DOI / 10.1136/esmoopen-2018-000448 Gold DOAJ, Green published
Mentions   0   Wikipedia   2   News   0   Policy
Article First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811 Chung, Hyun Cheol; Bang, Yung-Jue; S Fuchs, Charles; Qin, Shu-kui; Satoh, Taroh; Shitara, Kohei; Tabernero, Josep; Van Cutsem, Eric; Alsina, Maria; Cao, Zhu Alexander; Lu, Jia; Bhagia, Pooja; Shih, Chie-Schin; Janjigian, Yelena Y. FUTURE ONCOLOGY 1479-6694 (2020) DOI / 10.2217/fon-2020-0737 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material The Effective Targeting of KRAS(G12C) Elusiveness Elez, Filiation Elena; Tabernero, Josep CANCER CELL 1535-6108 (2020) DOI / 10.1016/j.ccell.2020.11.012
Mentions   0   Wikipedia   2   News   0   Policy
Article Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW Muro, Kei; Cho, Jae Yong; Bodoky, Gyorgy; Goswami, Chanchal; Chao, Yee; dos Santos, Lucas V.; Shimada, Yasuhiro; Topuzov, Eldar; Van Cutsem, Eric; Tabernero, Josep; Zalcberg, John; Chau, Ian; Cascinu, Stefano; Cheng, Rebecca; Hsu, Yanzhi; Emig, Michael; Or JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 0815-9319 (2018) DOI / 10.1111/jgh.14007
Mentions   0   Wikipedia   1   News   0   Policy
Article Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer Sclafani, Francesco; Brown, Gina; Cunningham, David; Wotherspoon, Andrew; Mendes, Larissa Sena Teixeira; Balyasnikova, Svetlana; Evans, Jessica; Peckitt, Clare; Begum, Ruwaida; Tait, Diana; Tabernero, Josep; Glimelius, Bengt; Rosello, Susana; Thomas, Janet BRITISH JOURNAL OF CANCER 0007-0920 (2017) DOI / 10.1038/bjc.2017.320 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material The Cancer Moonshot from a European perspective Ciardiello, Fortunato; Tabernero, Josep LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30798-2
Mentions   0   Wikipedia   0   News   0   Policy
Article The Transcription Factor SLUG Uncouples Pancreatic Cancer Progression from the RAF-MEK1/2-ERK1/2 Pathway Bilal, Faiz; Arenas, Enrique J.; Pedersen, Kim; Martinez-Sabadell, Alex; Nabet, Behnam; Guruceaga, Elizabeth; Vicent, Silvestre; Tabernero, Josep; Macarulla, Teresa; Arribas, Joaquin CANCER RESEARCH 0008-5472 (2021) DOI / 10.1158/0008-5472.can-20-4263 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective Soosaipillai, Gehan; Wu, Anjui; Dettorre, Gino M.; Diamantis, Nikolaos; Chester, John; Moss, Charlotte; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Brunet, Joan; Jones, Eleanor; Mesia, Ricard; Jackson, Amanda; Mukherjee, Uma THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 1758-8340 (2021) DOI / 10.1177/17588359211042224 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy Allen, Wendy L.; Dunne, Philip D.; Mcdade, Simon; Scanlon, Enya; Loughrey, Maurice; Coleman, Helen G.; McCann, Christopher; McLaughlin, Kristy; Nemeth, Zsuzsanna; Syed, Najeeb Ashraf; Jithesh, Puthen Veettil; Arthur, Ken; Wilson, Richard; Coyle, Vicky M.; JCO PRECISION ONCOLOGY (2018) DOI / 10.1200/po.17.00241 Green accepted, Green published, Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article Effect of Primary Tumor Location on Second-or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies Boeckx, Nele; Koukakis, Reija; Op de Beeck, Ken; Rolfo, Christian; Van Camp, Guy; Siena, Salvatore; Tabernero, Josep; Douillard, Jean-Yves; Andre, Thierry; Peeters, Marc CLINICAL COLORECTAL CANCER 1533-0028 (2018) DOI / 10.1016/j.clcc.2018.03.005 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure-response analysis Fudio, Salvador; Tabernero, Josep; Subbiah, Vivek; Chawla, Sant P.; Moreno, Victor; Longo, Federico; Lopez, Rafael; Anton, Antonio; Trigo, Jose Manuel; Shapiro, Geoffrey; Jeong, Woondong; Villalobos, Victor Manuel; Lubomirov, Rubin; Fernandez-Teruel, Carlo CANCER CHEMOTHERAPY AND PHARMACOLOGY 0344-5704 (2020) DOI / 10.1007/s00280-020-04153-6 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer Yoshino, T.; Argiles, G.; Oki, E.; Martinelli, E.; Taniguchi, H.; Arnold, D.; Mishima; Li, Y.; Smruti, B. K.; Ahn, J. B.; Faud, I.; Chee, C. E.; Yeh, K. -H.; Lin, P. -C.; Chua, C.; Hasbullah, H. H.; Lee, M. A.; Sharma, A.; Sun, Y.; Curigliano, G.; Bando, H ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.08.1752 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Enhancing global access to cancer medicines Cortes, Javier; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Curigliano, Giuseppe; El Saghir, Nagi S.; Cardoso, Fatima; Barrios, Carlos H.; Wagle, Shama; Roman, Javier; Harbeck, Nadia; Eniu, Alexandru; Kaufman, Peter A.; Tabernero, Josep; Garcia-Es CA-A CANCER JOURNAL FOR CLINICIANS 0007-9235 (2020) DOI / 10.3322/caac.21597 Gold
Mentions   0   Wikipedia   1   News   1   Policy
Article Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer Melisi, Davide; Garcia-Carbonero, Rocio; Macarulla, Teresa; Pezet, Denis; Deplanque, Gael; Fuchs, Martin; Trojan, Jorg; Oettle, Helmut; Kozloff, Mark; Cleverly, Ann; Smith, Claire; Estrem, Shawn T.; Gueorguieva, Ivelina; Lahn, Michael M. F.; Blunt, Al; Ben BRITISH JOURNAL OF CANCER 0007-0920 (2018) DOI / 10.1038/s41416-018-0246-z Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer Lafferty, Adam; O'Farrell, Alice C.; Migliardi, Giorgia; Khemka, Niraj; Lindner, Andreas U.; Sassi, Francesco; Zanella, Eugenia R.; Salvucci, Manuela; Vanderheyden, Evy; Modave, Elodie; Boeckx, Bram; Halang, Luise; Betge, Johannes; Ebert, Matthias P. A.; D CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-21-0818
Mentions   0   Wikipedia   1   News   0   Policy
Editorial Material SARS-CoV-2 vaccination and phase 1 cancer clinical trials Yap, Timothy A.; Siu, Lillian L.; Calvo, Emiliano; Lolkema, Martijn P.; LoRusso, Patricia M.; Soria, Jean-Charles; Plummer, Ruth; de Bono, Johann S.; Tabernero, Josep; Banerji, Udai LANCET ONCOLOGY 1470-2045 (2021) DOI / 10.1016/s1470-2045(21)00017-6 Bronze, Green published
Mentions   0   Wikipedia   0   News   1   Policy
Article Adjuvant FOLFOX plus /- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients Taieb, J.; Balogoun, R.; Le Malicot, K.; Tabernero, J.; Mini, E.; Folprecht, G.; Van Laethem, J. -L.; Emile, J. -F.; Mulot, C.; Fratte, S.; Levache, C. -B.; Saban-Roche, L.; Thaler, J.; Petersen, L. N.; Bridgewater, J.; Perkins, G.; Lepage, C.; Van Cutsem, ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdw687 Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer Garcia-Foncillas, Jesus; Tabernero, Josep; Elez, Elena; Aranda, Enrique; Benavides, Manuel; Camps, Carlos; Jantus-Lewintre, Eloisa; Lopez, Rafael; Muinelo-Romay, Laura; Montagut, Clara; Anton, Antonio; Lopez, Guillermo; Diaz-Rubio, Eduardo; Rojo, Federico; BRITISH JOURNAL OF CANCER 0007-0920 (2018) DOI / 10.1038/s41416-018-0293-5 Green published, Gold other, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies Sveen, Anita; Bruun, Jarle; Eide, Peter W.; Eilertsen, Ina A.; Ramirez, Lorena; Murumagi, Astrid; Arjama, Mariliina; Danielsen, Stine A.; Kryeziu, Kushtrim; Elez, Elena; Tabernero, Josep; Guinney, Justin; Palmer, Hector G.; Nesbakken, Arild; Kallioniemi, O CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-17-1234 Green published, Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Review Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines Grothey, A.; Fakih, M.; Tabernero, J. ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.03.206 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Review Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty Lordick, Florian; Obermannova, Radka; Vola, Doris; Douillard, Jean-Yves; McGregor, Keith; Van Cutsem, Eric; Tabernero, Josep; Ciardiello, Fortunato; Cervantes, Andres ESMO OPEN (2019) DOI / 10.1136/esmoopen-2019-000533 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer A Secondary Analysis of the AVANT Trial Chibaudel, Benoist; Henriques, Julie; Rakez, Manel; Brenner, Baruch; Kim, Tae Won; Martinez-Villacampa, Mercedes; Gallego-Plazas, Javier; Cervantes, Andres; Shim, Katharine; Jonker, Derek; Guerin-Meyer, Veronique; Mineur, Laurent; Banzi, Chiara; Dewdney, A JAMA NETWORK OPEN 2574-3805 (2020) DOI / 10.1001/jamanetworkopen.2020.20425 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study Tabernero, J.; Hozak, R. R.; Yoshino, T.; Cohn, A. L.; Obermannova, R.; Bodoky, G.; Garcia-Carbonero, R.; Ciuleanu, T-E; Portnoy, D. C.; Prausova, J.; Muro, K.; Siegel, R. W.; Konrad, R. J.; Ouyang, H.; Melemed, S. A.; Ferry, D.; Nasroulah, F.; Van Cutsem, ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdx767 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design Tabernero, Josep; Taieb, Julien; Prager, Gerald W.; Ciardiello, Fortunato; Fakih, Marwan; Leger, Catherine; Fougeray, Ronan; Amellal, Nadia; Van Cutsem, Eric FUTURE ONCOLOGY 1479-6694 (2021) DOI / 10.2217/fon-2020-1238 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules Dafni, Urania; Karlis, Dimitris; Pedeli, Xanthi; Bogaerts, Jan; Pentheroudakis, George; Tabernero, Josep; Zielinski, Christoph C.; Piccart, Martine J.; de Vries, Elisabeth G. E.; Latino, Nicola Jane; Douillard, Jean-Yves; Cherny, Nathan I. ESMO OPEN (2017) DOI / 10.1136/esmoopen-2017-000216 Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review How I treat gastric adenocarcinoma Alsina, Maria; Maria Miquel, Josep; Diez, Marc; Castro, Sandra; Tabernero, Josep ESMO OPEN (2019) DOI / 10.1136/esmoopen-2019-000521 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer Dasari, Arvind; Sobrero, Alberto; Yao, James; Yoshino, Takayuki; Schelman, William; Yang, Zhao; Chien, Caly; Kania, Marek; Tabernero, Josep; Eng, Cathy FUTURE ONCOLOGY 1479-6694 (2021) DOI / 10.2217/fon-2021-0202 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors Isakoff, S. J.; Tabernero, J.; Molife, L. R.; Soria, J. -C.; Cervantes, A.; Vogelzang, N. J.; Patel, M. R.; Hussain, M.; Baron, A.; Argiles, G.; Conkling, R.; Sampath, D.; Maslyar, D.; Patel, P.; Chan, W.; Gendreau, S.; Musib, L.; Xu, N.; Ma, H.; Lin, K.; ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.02.007 Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancer Elez, Elena; Chianese, Chiara; Sanz-Garcia, Enrique; Martinelli, Erica; Noguerido, Alba; Mattia Mancuso, Francesco; Caratu, Ginevra; Matito, Judit; Grasselli, Julieta; Cardone, Claudia; Abate, Riziero Esposito; Martini, Giulia; Santos, Cristina; Macarulla, MOLECULAR ONCOLOGY 1574-7891 (2019) DOI / 10.1002/1878-0261.12547 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer Ros, Javier; Baraibar, Iosune; Martini, Giulia; Salva, Francesc; Saoudi, Nadia; Luis Cuadra-Urteaga, Jose; Dienstmann, Rodrigo; Tabernero, Josep; Elez, Elena CURRENT TREATMENT OPTIONS IN ONCOLOGY 1527-2729 (2021) DOI / 10.1007/s11864-021-00913-5
Mentions   0   Wikipedia   0   News   0   Policy
Article Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Muro, K.; Van Cutsem, E.; Narita, Y.; Pentheroudakis, G.; Baba, E.; Li, J.; Ryu, M. -H.; Zamaniah, W. I. Wan; Yong, W. -P.; Yeh, K. -H.; Kato, K.; Lu, Z.; Cho, B. C.; Nor, I. M.; Ng, M.; Chen, L. -T.; Nakajima, T. E.; Shitara, K.; Kawakami, H.; Tsushima, T ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdy502 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Review Clinical development of therapies targeting TGF beta: current knowledge and future perspectives Ciardiello, D.; Elez, E.; Tabernero, J.; Seoane, J. ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.07.009 Gold other
Mentions   0   Wikipedia   0   News   1   Policy
Article A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer van Geel, Robin M. J. M.; Tabernero, Josep; Elez, Elena; Bendell, Johanna C.; Spreafico, Anna; Schuler, Martin; Yoshino, Takayuki; Delord, Jean-Pierre; Yamada, Yasuhide; Lolkema, Martijn P.; Faris, Jason E.; Eskens, Ferry A. L. M.; Sharma, Sunil; Yaeger, R CANCER DISCOVERY 2159-8274 (2017) DOI / 10.1158/2159-8290.cd-16-0795 Green accepted, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer Siena, S.; Sartore-Bianchi, A.; Garcia-Carbonero, R.; Karthaus, M.; Smith, D.; Tabernero, J.; Van Cutsem, E.; Guan, X.; Boedigheimer, M.; Ang, A.; Twomey, B.; Bach, B. A.; Jung, A. S.; Bardelli, A. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdx504 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Review Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology Goldberg, Richard M.; Adams, Richard; Buyse, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; Burzykowski, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021) DOI / 10.1093/jnci/djab218
Mentions   0   Wikipedia   0   News   0   Policy
Review Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies Smoragiewicz, M.; Bogaerts, J.; Calvo, E.; Marabelle, A.; Perrone, A.; Seymour, L.; Shalabi, A.; Siu, L. L.; Tabernero, J.; Giaccone, G.; Atkins, M.; Banerji, U.; Bates, S.; De Braud, F.; Douillard, J. Y.; Keegan, P.; Kumar, R.; Lorusso, P.; Pignatti, F.; ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy398 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Early evolutionary divergence between papillary and anaplastic thyroid cancers Capdevila, J.; Mayor, R.; Mancuso, F. M.; Iglesias, C.; Caratu, G.; Matos, I.; Zafon, C.; Hernando, J.; Petit, A.; Nuciforo, P.; Cameselle-Teijeiro, J. M.; Alvarez, C.; Recio, J. A.; Tabernero, J.; Matias-Guiu, X.; Vivancos, A.; Seoane, J. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy123 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Ohtsu, Atsushi; Tabernero, Josep; Ilson, David H.; Hyung, Woo Jin; Strong, Vivian E.; Goetze, Thorsten Oliver; Yoshikawa, Takaki; Tang, Laura H.; Hwang, Peggy May Tan; Webb, Nancy; Adelberg, David; Shita FUTURE ONCOLOGY 1479-6694 (2019) DOI / 10.2217/fon-2018-0581 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study Tempero, M.; Oh, D-Y; Tabernero, J.; Reni, M.; Van Cutsem, E.; Hendifar, A.; Waldschmidt, D-T; Starling, N.; Bachet, J-B; Chang, H-M; Maurel, J.; Garcia-Carbonero, R.; Lonardi, S.; Coussens, L. M.; Fong, L.; Tsao, L. C.; Cole, G., Jr.; James, D.; Macarulla ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.01.070 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Review Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis Spindler, Karen-Lise G.; Boysen, Anders K.; Pallisgard, Niels; Johansen, Julia S.; Tabernero, Josep; Sorensen, Morten M.; Jensen, Benny V.; Hansen, Torben F.; Sefrioui, David; Andersen, Rikke F.; Brandslund, Ivan; Jakobsen, Anders ONCOLOGIST 1083-7159 (2017) DOI / 10.1634/theoncologist.2016-0178 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial Auclin, Edouard; Andre, Thierry; Taieb, Julien; Banzi, Maria; Van Laethem, Jean-Luc; Tabernero, Josep; Hickish, Tamas; de Gramont, Aimery; Vernerey, Dewi BRITISH JOURNAL OF CANCER 0007-0920 (2019) DOI / 10.1038/s41416-019-0521-7 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score >= 10 Wainberg, Zev A.; Fuchs, Charles S.; Tabernero, Josep; Shitara, Kohei; Muro, Kei; Van Cutsem, Eric; Bang, Yung-Jue; Chung, Hyun Cheol; Yamaguchi, Kensei; Varga, Eniko; Chen, Jen-Shi; Hochhauser, Daniel; Thuss-Patience, Peter; Al-Batran, Salah-Eddin; Garrid CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-20-2980
Mentions   0   Wikipedia   0   News   0   Policy
Article Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT) Smoragiewicz, Martin; Adjei, Alex A.; Calvo, Emiliano; Tabernero, Josep; Marabelle, Aurelien; Massard, Christophe; Tang, Jun; de Vries, Elisabeth G. E.; Douillard, Jean-Yves; Seymour, Lesley CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-3136
Mentions   0   Wikipedia   0   News   0   Policy
Review Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer Baraibar, Iosune; Mirallas, Oriol; Saoudi, Nadia; Ros, Javier; Salva, Francesc; Tabernero, Josep; Elez, Elena CANCERS (2021) DOI / 10.3390/cancers13246311
Mentions   0   Wikipedia   0   News   0   Policy
Article Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer Serna, Garazi; Ruiz-Pace, Fiorella; Cecchi, Fabiola; Fasani, Roberta; Jimenez, Jose; Thyparambil, Sheen; Landolfi, Stefania; Elez, Elena; Vivancos, Ana; Hembrough, Todd; Tabernero, Josep; Dienstmann, Rodrigo; Nuciforo, Paolo SCIENTIFIC REPORTS 2045-2322 (2019) DOI / 10.1038/s41598-019-49867-7 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine Sonbol, Mohamad Bassam; Ahn, Daniel H.; Goldstein, David; Okusaka, Takuji; Tabernero, Josep; Macarulla, Teresa; Reni, Michele; Li, Chung-Pin; O'Neil, Bert; Van Cutsem, Eric; Bekaii-Saab, Tanios FUTURE ONCOLOGY 1479-6694 (2019) DOI / 10.2217/fon-2018-0903
Mentions   0   Wikipedia   0   News   0   Policy
Article Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Muro, K.; Lordick, F.; Tsushima, T.; Pentheroudakis, G.; Baba, E.; Lu, Z.; Cho, B. C.; Nor, I. M.; Ng, M.; Chen, L. -T.; Kato, K.; Li, J.; Ryu, M. -H.; Zamaniah, W. I. Wan; Yong, W. -P.; Yeh, K. -H.; Nakajima, T. E.; Shitara, K.; Kawakami, H.; Narita, Y.; ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdy498 Gold other
Mentions   0   Wikipedia   0   News   1   Policy
Article nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACACT trial Tabernero, Josep; Kunzmann, Volker; Scheithauer, Werner; Reni, Michele; Li, Jack Shiansong; Ferrara, Stefano; Djazouli, Kamel ONCOTARGETS AND THERAPY 1178-6930 (2017) DOI / 10.2147/ott.s124097 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Back-to-Back Discovery, Co-Precision, and Prevention Casadei, Barbara; Tabernero, Josep JACC: CARDIOONCOLOGY 2666-0873 (2019) DOI / 10.1016/j.jaccao.2019.11.015 Gold DOAJ
Mentions   0   Wikipedia   0   News   0   Policy
Article Future care for long-term cancer survivors: towards a new model Provencio, M.; Romero, N.; Tabernero, J.; Vera, R.; Baz, D., V; Arraiza, A.; Camps, C.; Felip, E.; Garrido, P.; Gaspar, B.; Llombart, M.; Lopez, A.; Ibanez, V. M.; Olmos, J. M.; Mur, C.; Navarro-Ruiz, A.; Pastor, A.; Peiro, M.; Polo, J.; Rodriguez-Lescure, CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2021) DOI / 10.1007/s12094-021-02696-5 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Review Strategies to design clinical studies to identify predictive biomarkers in cancer research Perez-Gracia, Jose Luis; Sanmamed, Miguel F.; Bosch, Ana; Patino-Garcia, Ana; Schalper, Kurt A.; Segura, Victor; Bellmunt, Joaquim; Tabernero, Josep; Sweeney, Christopher J.; Choueiri, Toni K.; Martin, Miguel; Pablo Fusco, Juan; Esperanza Rodriguez-Ruiz, M CANCER TREATMENT REVIEWS 0305-7372 (2017) DOI / 10.1016/j.ctrv.2016.12.005 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial Yoshino, Takayuki; Obermannova, Radka; Bodoky, Gyorgy; Garcia-Carbonero, Rocio; Ciuleanu, Tudor; Portnoy, David C.; Kim, Tae Won; Hsu, Yanzhi; Ferry, David; Nasroulah, Federico; Tabernero, Josep EUROPEAN JOURNAL OF CANCER 0959-8049 (2017) DOI / 10.1016/j.ejca.2017.03.007 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer Taieb, Julien; Le Malicot, Karine; Shi, Qian; Penault-Llorca, Frederique; Bouche, Olivier; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Van Laethem, Jean Luc; Sargent, Daniel J.; Alberts, Steven R.; Emile, Jean Francois; Laurent JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 0027-8874 (2017) DOI / 10.1093/jnci/djw272 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology Castelo-Branco, L.; Awada, A.; Pentheroudakis, G.; Perez-Gracia, J. L.; Mateo, J.; Curigliano, G.; Banerjee, S.; Giuliani, R.; Lordick, F.; Cervantes, A.; Tabernero, J.; Peters, S. ESMO OPEN (2021) DOI / 10.1016/j.esmoop.2021.100237 Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review New clinical trial designs in the era of precision medicine Garralda, Elena; Dienstmann, Rodrigo; Piris-Gimenez, Alejandro; Brana, Irene; Rodon, Jordi; Tabernero, Josep MOLECULAR ONCOLOGY 1574-7891 (2019) DOI / 10.1002/1878-0261.12465 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article BRAF-Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer Middleton, Gary; Yang, Yiqun; Campbell, Catarina D.; Andre, Thierry; Atreya, Chloe E.; Schellens, Jan H. M.; Yoshino, Takayuki; Bendell, Johanna C.; Hollebecque, Antoine; McRee, Autumn J.; Siena, Salvatore; Gordon, Michael S.; Tabernero, Josep; Yaeger, Ron CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-3579 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy Gallois, Claire; Taieb, Julien; Le Corre, Delphine; Le Malicot, Karine; Tabernero, Josep; Mulot, Claire; Seitz, Jean-Francois; Aparicio, Thomas; Folprecht, Gunnar; Lepage, Come; Mini, Enrico; Van Laethem, Jean-Luc; Emile, Jean-Francois; Laurent-Puig, Pierr CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-18-0866 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials Zaanan, Aziz; Shi, Qian; Taieb, Julien; Alberts, Steven R.; Meyers, Jeffrey P.; Smyrk, Thomas C.; Julie, Catherine; Zawadi, Ayman; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Van Laethem, Jean Luc; Le Malicot, Karine; Sargent, JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.19.00237 Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3K alpha Isoform Inhibitor, in Patients with Advanced Solid Malignancies Juric, Dejan; de Bono, Johann S.; LoRusso, Patricia M.; Nemunaitis, John; Heath, Elisabeth I.; Kwak, Eunice L.; Macarulla Mercade, Teresa; Geuna, Elena; de Miguel-Luken, Maria Jose; Patel, Chirag; Kuida, Keisuke; Sankoh, Serap; Westin, Eric H.; Zohren, Fab CLINICAL CANCER RESEARCH 1078-0432 (2017) DOI / 10.1158/1078-0432.ccr-16-2888 Green accepted, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study Kagawa, Yoshinori; Elez, Elena; Garcia-Foncillas, Jesus; Bando, Hideaki; Taniguchi, Hiroya; Vivancos, Ana; Akagi, Kiwamu; Garcia, Ariadna; Denda, Tadamichi; Ros, Javier; Nishina, Tomohiro; Baraibar, Iosune; Komatsu, Yoshito; Ciardiello, Davide; Oki, Eiji; CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-20-3677
Mentions   0   Wikipedia   0   News   0   Policy
Article Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials Sinicrope, Frank A.; Chakrabarti, Sakti; Laurent-Puig, Pierre; Huebner, Luke; Smyrk, Thomas C.; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Zaanan, Aziz; Folprecht, Gunnar; Van Laethem, Jean Luc; Le Malicot, Karine; Shi, Qian; Alberts, Steven R.; EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2020.11.016
Mentions   0   Wikipedia   0   News   0   Policy
Article Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX Emile, Jean-Francois; Julie, Catherine; Le Malicot, Karine; Lepage, Come; Tabernero, Josep; Mini, Enrico; Folprecht, Gunnar; Van Laethem, Jean-Luc; Dimet, Stephanie; Boulagnon-Rombi, Camille; Allard, Marc-Antoine; Penault-Llorca, Frederique; Bennouna, Jaaf EUROPEAN JOURNAL OF CANCER 0959-8049 (2017) DOI / 10.1016/j.ejca.2017.04.025
Mentions   0   Wikipedia   0   News   0   Policy
Article Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAF(V600) Mutations: A Cohort of the Histology-Independent VE-BASKET Study Raje, Noopur; Chau, Ian; Hyman, David M.; Ribrag, Vincent; Blay, Jean-Yves; Tabernero, Josep; Elez, Elena; Wolf, Jurgen; Yee, Andrew J.; Kaiser, Martin; Landau, Heather; Michot, Jean-Marie; Hollebecque, Antoine; Veronese, Luisa; Makrutzki, Martina; Pitcher JCO PRECISION ONCOLOGY (2018) DOI / 10.1200/po.18.00070 Green published
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Towards a Cancer Mission in Horizon Europe Berns, Anton; Ringborg, Ulrik; Eggermont, Alexander; Baumann, Michael; Calvo, Fabien; Eggert, Angelika; Espina, Carolina; Hanahan, Douglas; Lacombe, Denis; de Lorenzo, Francesco; Oberst, Simon; Philip, Thierry; Schuz, Joachim; Tabernero, Josep; Celis, Juli MOLECULAR ONCOLOGY 1574-7891 (2019) DOI / 10.1002/1878-0261.12585 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Two-way traffic: aligning expectations with current realities in oncology. Mid-term ESMO Presidency considerations Tabernero, Josep ESMO OPEN (2019) DOI / 10.1136/esmoopen-2019-000494 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab Arnold, D.; Fuchs, C. S.; Tabernero, J.; Ohtsu, A.; Zhu, A. X.; Garon, E. B.; Mackey, J. R.; Paz-Ares, L.; Baron, A. D.; Okusaka, T.; Yoshino, T.; Yoon, H. H.; Das, M.; Ferry, D.; Zhang, Y.; Lin, Y.; Binder, P.; Sashegyi, A.; Chau, I. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx514 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors Elez, Elena; Gomez-Roca, Carlos; Soto Matos-Pita, Arturo; Argiles, Guillem; Valentin, Thibaud; Coronado, Cinthya; Iglesias, Jorge; Macarulla, Teresa; Betrian, Sarah; Fudio, Salvador; Zaragoza, Katrin; Tabernero, Josep; Delord, Jean-Pierre INVESTIGATIONAL NEW DRUGS 0167-6997 (2019) DOI / 10.1007/s10637-018-0674-x
Mentions   0   Wikipedia   0   News   0   Policy
Article Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies Boeckx, N.; Koukakis, R.; de Beeck, K. Op; Rolfo, C.; Van Camp, G.; Siena, S.; Tabernero, J.; Douillard, J. -Y.; Andre, T.; Peeters, M. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx119 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer Tabernero, Josep; Van Cutsem, Eric; Ohtsu, Atsushi; Amellal, Nadia; Cadour, Stephanie; Fougeray, Ronan; Haffemayer, Benjamin; Mayer, Robert J. ESMO OPEN (2017) DOI / 10.1136/esmoopen-2017-000284 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer Goldstein, David; Von Hoff, Daniel D.; Chiorean, E. Gabriela; Reni, Michele; Tabernero, Josep; Ramanathan, Ramesh K.; Botteman, Marc; Aly, Abdalla; Margunato-Debay, Sandra; Lu, Brian; Louis, Chrystal U.; McGovern, Desmond; Lee, Chee Khoon PANCREAS 0885-3177 (2020) DOI / 10.1097/mpa.0000000000001563 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial Cohn, Allen Lee; Yoshino, Takayuki; Heinemann, Volker; Obermannova, Radka; Bodoky, Gyorgy; Prausova, Jana; Garcia-Carbonero, Rocio; Ciuleanu, Tudor; Garcia-Alfonso, Pilar; Portnoy, David C.; Van Cutsem, Eric; Yamazaki, Kentaro; Clingan, Philip R.; Polikoff CANCER CHEMOTHERAPY AND PHARMACOLOGY 0344-5704 (2017) DOI / 10.1007/s00280-017-3380-z Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients Elez, Elena; Pericay, Caries; Valladares-Ayerbes, Manuel; Bando, Inmaculada; Safont, Maria Jose; Gallego, Javier; Gravalos, Cristina; Arrivi, Antonio; Carrato, Alfredo; Conde, Veronica; Jose Ortiz, Maria; Lopez, Carlos; Alonso, Beatriz; Ruiz de Mena, Inmac BRITISH JOURNAL OF CANCER 0007-0920 (2019) DOI / 10.1038/s41416-019-0537-z Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors Saura, Cristina; Roda, Desamparados; Rosello, Susana; Oliveira, Mafalda; Macarulla, Teresa; Alejandro Perez-Fidalgo, Jose; Morales-Barrera, Rafael; Manuel Sanchis-Garcia, Juan; Musib, Luna; Budha, Nageshwar; Zhu, Jin; Nannini, Michelle; Chan, Wai Y.; Bohor CANCER DISCOVERY 2159-8274 (2017) DOI / 10.1158/2159-8290.cd-16-0512 Green accepted, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma Tabernero, Josep; Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Janjigian, Yelena Yuriy; Bhagia, Pooja; Li, Kan; Adelberg, David; Qin, Shu Kui FUTURE ONCOLOGY 1479-6694 (2021) DOI / 10.2217/fon-2021-0176 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Up-to-date role of aflibercept in the treatment of colorectal cancer Saoudi Gonzalez, Nadia; Salva, Francesc; Ros, Javier; Baraibar, Iosune; Marmolejo, David; Valdivia, Augusto; Luis Cuadra-Urteaga, Jose; Mulet, Nuria; Tabernero, Josep; Elez, Elena EXPERT OPINION ON BIOLOGICAL THERAPY 1471-2598 (2021) DOI / 10.1080/14712598.2021.1935231
Mentions   0   Wikipedia   0   News   0   Policy
Article Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial Elez, Elena; Auxiliadora Gomez-Espana, Maria; Gravalos, Cristina; Garcia-Alfonso, Pilar; Jose Ortiz-Morales, Maria; Losa, Ferran; Ales Diaz, Inmaculada; Grana, Begona; Toledano-Fonseca, Marta; Valladares-Ayerbes, Manuel; Polo, Eduardo; Salgado, Mercedes; M BRITISH JOURNAL OF CANCER (2021) DOI / 10.1038/s41416-021-01638-w
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Building bridges between drug development and cancer science: a tribute to Jose Baselga's legacy Hyman, D. M.; Soria, J. -C.; Tabernero, J. ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.03.209 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study Bordonaro, R.; Calvo, A.; Auriemma, A.; Hollebecque, A.; Rubovszky, G.; Saunders, M. P.; Papai, Z.; Prager, G.; Stein, A.; Andre, T.; Argiles, G.; Cubillo, A.; Dahan, L.; Edeline, J.; Leger, C.; Cattan, V.; Fougeray, R.; Amellal, N.; Tabernero, J. ESMO OPEN (2021) DOI / 10.1016/j.esmoop.2021.100270 Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy Vidal, J.; Bellosillo, B.; Santos Vivas, C.; Garcia-Alfonso, P.; Carrato, A.; Cano, M. T.; Garcia-Carbonero, R.; Elez, E.; Losa, F.; Massuti, B.; Valladares-Ayerbes, M.; Vieitez, J. M.; Manzano, J. L.; Azuara, D.; Gallego, J.; Pairet, S.; Capella, G.; Sala ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz005 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Review Cancer Core Europe: A translational research infrastructure for a European mission on cancer Eggermont, Alexander M. M.; Apolone, Giovanni; Baumann, Michael; Caldas, Carlos; Celis, Julio E.; de Lorenzo, Francesco; Ernberg, Ingemar; Ringborg, Ulrik; Rowell, John; Tabernero, Josep; Voest, Emile; Calvo, Fabien MOLECULAR ONCOLOGY 1574-7891 (2019) DOI / 10.1002/1878-0261.12447 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer Ros, Javier; Baraibar, Iosune; Sardo, Emilia; Mulet, Nuria; Salva, Francesc; Argiles, Guillem; Martini, Giulia; Ciardiello, Davide; Cuadra, Jose Luis; Tabernero, Josep; Elez, Elena THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 1758-8340 (2021) DOI / 10.1177/1758835921992974 Gold DOAJ
Mentions   0   Wikipedia   0   News   0   Policy
Article Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer Mendez, Olga; Peg, Vicente; Salvans, Candida; Pujals, Mireia; Fernandez, Yolanda; Abasolo, Ibane; Perez, Jose; Matres, Ana; Valeri, Marta; Gregori, Josep; Villarreal, Laura; Schwartz, Simo, Jr.; Ramon y Cajal, Santiago; Tabernero, Josep; Cortes, Javier; Ar CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-18-0517 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer Santos, Cristina; Azuara, Daniel; Garcia-Carbonero, Rocio; Garcia Alfonso, Pilar; Carrato, Alfredo; Elena Elez, Ma; Gomez, Auxiliadora; Losa, Ferran; Montagut, Clara; Massuti, Bartomeu; Navarro, Valenti; Varela, Mar; Lopez-Doriga, Adriana; Moreno, Victor; MOLECULAR CANCER THERAPEUTICS 1535-7163 (2017) DOI / 10.1158/1535-7163.mct-17-0153 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Pancreatic cancer heterogeneity and response to Mek inhibition Pedersen, K.; Bilal, F.; Bernado Morales, C.; Salcedo, M. T.; Macarulla, T.; Masso-Valles, D.; Mohan, V.; Vivancos, A.; Carreras, M-J; Serres, X.; Abu-Suboh, M.; Balsells, J.; Allende, E.; Sagi, I.; Soucek, L.; Tabernero, J.; Arribas, J. ONCOGENE 0950-9232 (2017) DOI / 10.1038/onc.2017.174
Mentions   0   Wikipedia   0   News   0   Policy
Article MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach Schmoll, Hans-Joachim; Arnold, Dirk; de Gramont, Aimery; Ducreux, Michel; Grothey, Axel; O'Dwyer, Peter J.; Van Cutsem, Eric; Hermann, Frank; Bosanac, Ivan; Bendahmane, Belguendouz; Mancao, Christoph; Tabernero, Josep JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 0171-5216 (2018) DOI / 10.1007/s00432-018-2632-6
Mentions   0   Wikipedia   0   News   0   Policy
Article Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century Calvo, Fabien; Apolone, Giovanni; Baumann, Michael; Caldas, Carlos; Celis, Julio E.; de Lorenzo, Franceso; Ernberg, Ingemar; Ringborg, Ulrik; Rowell, John; Tabernero, Josep; Voest, Emile; Eggermont, Alexander EUROPEAN JOURNAL OF CANCER 0959-8049 (2018) DOI / 10.1016/j.ejca.2018.08.023
Mentions   0   Wikipedia   0   News   0   Policy
Article Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS Tabernero, Josep; Alsina, Maria; Shitara, Kohei; Doi, Toshihiko; Dvorkin, Mikhail; Mansoor, Wasat; Arkenau, Hendrik-Tobias; Prokharau, Aliaksandr; Ghidini, Michele; Faustino, Catia; Gorbunova, Vera; Zhavrid, Edvard; Nishikawa, Kazuhiro; Ando, Takayuki; Yal GASTRIC CANCER 1436-3291 (2020) DOI / 10.1007/s10120-020-01053-9 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A new Light in the Darkness Rodon, Jordi; Tabernero, Josep CANCER DISCOVERY 2159-8274 (2017) DOI / 10.1158/2159-8290.cd-17-0500 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients Alsina, Maria; Rivera, Fernando; Javier Ramos, Francisco; Galan, Maica; Lopez, Rafael; Garcia-Alfonso, Pilar; Enrique Ales-Martinez, Jose; Queralt, Bernardo; Anton, Antonio; Carrato, Alfredo; Gravalos, Cristina; Jose Mendez-Vidal, Maria; Lopez, Carlos; Rui TARGETED ONCOLOGY 1776-2596 (2018) DOI / 10.1007/s11523-017-0536-z
Mentions   0   Wikipedia   0   News   0   Policy
Article Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib Malhi, Vikram; Budha, Nageshwar; Sane, Rucha; Huang, Jian; Liederer, Bianca; Meng, Raymond; Patel, Premal; Deng, Yuzhong; Cervantes, Andres; Tabernero, Josep; Musib, Luna CANCER CHEMOTHERAPY AND PHARMACOLOGY 0344-5704 (2021) DOI / 10.1007/s00280-021-04344-9
Mentions   0   Wikipedia   0   News   0   Policy
Article Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial Longo-Munoz, F.; Argiles, G.; Tabernero, J.; Cervantes, A.; Gravalos, C.; Pericay, C.; Gil-Calle, S.; Mizuguchi, H.; Carrato-Mena, A.; Limon, M. L.; Garcia-Carbonero, R. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2017) DOI / 10.1007/s12094-016-1528-7 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis Salcedo Allende, Maria Teresa; Zenon-Medina, Jorge; Hernandez, Javier; Macarulla, Teresa; Balsells, Joaquim; Merino, Xavier; Allende, Helena; Tabernero, Josep; Ramon y Cajal Agueras, Santiago PANCREAS 0885-3177 (2017) DOI / 10.1097/mpa.0000000000000867
Mentions   0   Wikipedia   0   News   0   Policy
Letter Reply to the letter to the editor 'Can we trust burnout research?' by Bianchi et al. Banerjee, S.; Preusser, M.; Tabernero, J.; Strijbos, M. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx329 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer Wainberg, Zev A.; Alsina, Maria; Soares, Heloisa P.; Brana, Irene; Britten, Carolyn D.; Del Conte, Gianluca; Ezeh, Patrick; Houk, Brett; Kern, Kenneth A.; Leong, Stephen; Pathan, Nuzhat; Pierce, Kristen J.; Siu, Lillian L.; Vermette, Jennifer; Tabernero, J TARGETED ONCOLOGY 1776-2596 (2017) DOI / 10.1007/s11523-017-0530-5 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial Sclafani, Francesco; Kim, Tae Y.; Cunningham, David; Kim, Tae W.; Tabernero, Josep; Schmoll, Hans J.; Roh, Jae K.; Kim, Sun Y.; Park, Young S.; Guren, Tormod K.; Hawkes, Eliza; Clarke, Stephen J.; Ferry, David; Frodin, Jan-Erik; Ayers, Mark; Nebozhyn, Mich INTERNATIONAL JOURNAL OF CANCER 0020-7136 (2017) DOI / 10.1002/ijc.30453
Mentions   0   Wikipedia   0   News   0   Policy
Article Identification of Expression Profiles Defining Distinct Prognostic Subsets of Radioactive-Iodine Refractory Differentiated Thyroid Cancer from the DECISION Trial Capdevila, Jaume; Matos, Ignacio; Mancuso, Francesco M.; Iglesias, Carmela; Nuciforo, Paolo; Zafon, Carles; Palmer, Hector G.; Ogbah, Zighereda; Muinos, Laura; Hernando, Jorge; Villacampa, Guillermo; Pena, Carol E.; Tabernero, Josep; Brose, Marcia S.; Schl MOLECULAR CANCER THERAPEUTICS 1535-7163 (2020) DOI / 10.1158/1535-7163.mct-19-0211
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study Taniguchi, Hiroya; Yoshino, Takayuki; Yamaguchi, Kensei; Yamazaki, Kentaro; Nixon, Andrew B.; Tabernero, Josep; Van Cutsem, Eric; Robling, Kim R.; Abada, Paolo B.; Hozak, Rebecca R.; Siegel, Robert; Fill, Jeffrey A.; Wijayawardana, Sameera; Walgren, Richar CURRENT MEDICAL RESEARCH AND OPINION 0300-7995 (2021) DOI / 10.1080/03007995.2021.1940908
Mentions   0   Wikipedia   0   News   0   Policy
Letter ESMO-MCBS: setting the record straight Cherny, Nathan I.; Tabernero, Josep; de Vries, Elisabeth G. E. LANCET ONCOLOGY 1470-2045 (2019) DOI / 10.1016/s1470-2045(19)30174-3
Mentions   0   Wikipedia   0   News   0   Policy
Article Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO Chen, L-T; Martinelli, E.; Cheng, A-L; Pentheroudakis, G.; Qin, S.; Bhattacharyya, G. S.; Ikeda, M.; Lim, H-Y; Ho, G. F.; Choo, S. P.; Ren, Z.; Malhotra, H.; Ueno, M.; Ryoo, B-Y; Kiang, T. C.; Tai, D.; Vogel, A.; Cervantes, A.; Lu, S-N; Yen, C-J; Huang, Y- ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2019.12.001 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Back-to-back discovery, co-precision, and prevention Casadei, Barbara; Tabernero, Josep EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES 2058-5225 (2020) DOI / 10.1093/ehjqcco/qcz064 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Data Paper A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS Lieu, Christopher H.; Hidalgo, Manuel; Berlin, Jordan D.; Ko, Andrew H.; Cervantes, Andres; LoRusso, Patricia; Gerber, David E.; Eder, J. Paul; Eckhardt, S. Gail; Kapp, Amy V.; Tsuhako, Amy; McCall, Bruce; Pirzkall, Andrea; Uyei, Anne; Tabernero, Josep ONCOLOGIST 1083-7159 (2017) DOI / 10.1634/theoncologist.2017-0175 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer Hill, Andrew G.; Findlay, Michael P.; Burge, Matthew E.; Jackson, Christopher; Alfonso, Pilar Garcia; Samuel, Leslie; Ganju, Vinod; Karthaus, Meinolf; Amatu, Alessio; Jeffery, Mark; Di Bartolomeo, Maria; Bridgewater, John; Coveler, Andrew L.; Hidalgo, Manu CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-17-0646 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set Grothey, Axel; Yoshino, Takayuki; Bodoky, Gyorgy; Ciuleanu, Tudor; Garcia-Carbonero, Rocio; Garcia-Alfonso, Pilar; Van Cutsem, Eric; Muro, Kei; Mytelka, Daniel S.; Li, LI; Lipkovich, Olga; Hsu, Yanzhi; Sashegyi, Andreas; Ferry, David; Nasroulah, Federico; ESMO OPEN (2018) DOI / 10.1136/esmoopen-2018-000347 Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study Mansoor, Wasat; Arkenau, Hendrik-Tobias; Alsina, Maria; Shitara, Kohei; Thuss-Patience, Peter; Cuffe, Sinead; Dvorkin, Mikhail; Park, David; Ando, Takayuki; Van den Eynde, Marc; Beretta, Giordano D.; Zaniboni, Alberto; Doi, Toshihiko; Tabernero, Josep; Ils GASTRIC CANCER 1436-3291 (2021) DOI / 10.1007/s10120-021-01156-x Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights Dienstmann, Rodrigo; Elez, Elena; Argiles, Guillem; Matos, Ignacio; Sanz-Garcia, Enrique; Ortiz, Carolina; Macarulla, Teresa; Capdevila, Jaume; Alsina, Maria; Sauri, Tamara; Verdaguer, Helena; Vilaro, Marta; Ruiz-Pace, Fiorella; Viaplana, Cristina; Garcia, MOLECULAR ONCOLOGY 1574-7891 (2017) DOI / 10.1002/1878-0261.12099 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer Reynolds, Kerry Lynn; Bedard, Philippe L.; Lee, Se-Hoon; Lin, Chia-Chi; Tabernero, Josep; Alsina, Maria; Cohen, Ezra; Baselga, Jose; Blumenschein, George, Jr.; Graham, Donna M.; Garrido-Laguna, Ignacio; Juric, Dejan; Sharma, Sunil; Salgia, Ravi; Seroutou, BMC CANCER (2017) DOI / 10.1186/s12885-017-3641-6 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer Argiles, Guillem; Andre, Thierry; Hollebecque, Antoine; Calvo, Aitana; Dahan, Laetitia; Cervantes, Andres; Leger, Catherine; Amellal, Nadia; Fougeray, Ronan; Tabernero, Josep EUROPEAN JOURNAL OF CANCER 0959-8049 (2019) DOI / 10.1016/j.ejca.2019.01.101
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Value assessment frameworks in oncology: championing concordance through shared standards Bertagnolli, M.; Tabernero, J. ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz057 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: Post hoc Analysis of the MOSAIC and PETACC-8 Trials Auclin, Edouard; Taieb, Julien; Lepage, Come; Aparicio, Thomas; Faroux, Roger; Mini, Enrico; Folprecht, Gunnar; Salazar, Ramon; Benetkiewicz, Magdalena; Banzi, Maria; Louvet, Christophe; Van Laethem, Jean-Luc; Tabernero, Josep; Hickish, Tamas; de Gramont, CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 1055-9965 (2019) DOI / 10.1158/1055-9965.epi-18-0867 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer Tabernero, Josep; Ohtsu, Atsushi; Muro, Kei; Van Cutsem, Eric; Oh, Sang Cheul; Bodoky, Gyorgy; Shimada, Yasuhiro; Hironaka, Shuichi; Ajani, Jaffer A.; Tomasek, Jiri; Safran, Howard; Chandrawansa, Kumari; Hsu, Yanzhi; Heathman, Michael; Khan, Azhar; Ni, Lan MOLECULAR CANCER THERAPEUTICS 1535-7163 (2017) DOI / 10.1158/1535-7163.mct-16-0895 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Letter Reply to the letter to the editor 'Toxicity adjustment in the ESMO-MCBS: a Gestalt approach?' by Del Paggio Toxicity adjustment in the ESMO-MCBS: a diligent process of data interpretation with peer review that is far from 'Gestalt' Cherny, N. I.; Dafni, U.; Bogaerts, J.; Latino, N. J.; Pentheroudakis, G.; Douillard, J. -Y.; Tabernero, J.; Zielinski, C.; Piccart, M. J.; De Vries, E. G. E. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdx649 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group Andre, T.; Vernerey, D.; Im, S. A.; Bodoky, G.; Buzzoni, R.; Reingold, S.; Rivera, F.; McKendrick, J.; Scheithauer, W.; Ravit, G.; Fountzilas, G.; Yong, W. P.; Isaacs, R.; Osterlund, P.; Liang, J. T.; Creemers, G. J.; Rakez, M.; Van Cutsem, E.; Cunningham, ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2019.12.006
Mentions   0   Wikipedia   0   News   0   Policy
Letter RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Cherny, Nathan I.; Dafni, Urani; Bogaerts, Jan; Latino, Nicola J.; Pentheroudakis, George; Douillard, Jean-Yves; Tabernero, Josep; Zielinski, Christoph; Piccart, Martine J.; de Vries, Elisabeth G. E. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 0027-8874 (2018) DOI / 10.1093/jnci/djy029 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-beta inhibitor galunisertib in patients with pancreatic cancer Gueorguieva, Ivelina; Tabernero, Josep; Melisi, Davide; Macarulla, Teresa; Merz, Valeria; Waterhouse, Timothy H.; Miles, Colin; Lahn, Michael M.; Cleverly, Ann; Benhadji, Karim A. CANCER CHEMOTHERAPY AND PHARMACOLOGY 0344-5704 (2019) DOI / 10.1007/s00280-019-03931-1
Mentions   0   Wikipedia   0   News   0   Policy
Letter Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer-Reply Shitara, Kohei; Tabernero, Josep JAMA ONCOLOGY 2374-2437 (2021) DOI / 10.1001/jamaoncol.2020.8011
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material DPYD genotype-guided fluoropyrimidines dose: is it ready for prime time? Paez, D.; Salazar, R.; Tabernero, J. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx632 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial Van Cutsem, Eric; Falcone, Alfredo; Garcia-Carbonero, Rocio; Komatsu, Yoshito; Pastorino, Alessandro; Peeters, Marc; Shimada, Yasuhiro; Yamazaki, Kentaro; Yoshino, Takayuki; Zaniboni, Alberto; Amellal, Nadia; Kanehisa, Akira; Winkler, Robert; Makris, Lukas ESMO OPEN (2017) DOI / 10.1136/esmoopen-2017-000261 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article TGF beta receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer Melisi, Davide; Garcia-Carbonero, Rocio; Macarulla, Teresa; Pezet, Denis; Deplanque, Gael; Fuchs, Martin; Trojan, Jorg; Kozloff, Mark; Simionato, Francesca; Cleverly, Ann; Smith, Claire; Wang, Shuaicheng; Man, Michael; Driscoll, Kyla E.; Estrem, Shawn T.; CANCER CHEMOTHERAPY AND PHARMACOLOGY 0344-5704 (2019) DOI / 10.1007/s00280-019-03807-4
Mentions   0   Wikipedia   0   News   0   Policy
Article Impact of Prior Bevacizumab Treatment on VEGF-A and PIGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial Van Cutsem, Eric; Paccard, Caroline; Chiron, Marielle; Tabernero, Josep CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-1985 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material ESMO pays tribute to Professor Jose Baselga Peters, S.; Tabernero, J.; Cervantes, A.; Banerjee, S.; Giuliani, R.; Lordick, F. ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.04.001 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Review Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update Baraibar, Iosune; Ros, Javier; Mulet, Nuria; Salva, Francesc; Argiles, Guillem; Martini, Giulia; Cuadra, Jose Luis; Sardo, Emilia; Ciardiello, Davide; Tabernero, Josep; Elez, Elena EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 1473-7159 (2020) DOI / 10.1080/14737159.2020.1782194

Más rankings

InfluScience

Contacto
Cerrar